Marvell Technology (MRVL) Stock Sees Fair Value Cut After Mixed ...
π Marvell Technology's fair value estimate was cut from US$339.36 to US$317.60 following the Lumentum acquisition announcement.
π€ Analysts at B. Riley and Morgan Stanley view the Lumentum deal as a strategic expansion of the AI optical connectivity market to roughly US$550 billion by 2030.
β οΈ TD Cowen and BofA flag the acquisition as initially earnings dilutive due to integration risks and potential regulatory delays.
π Multiple firms reduced price targets citing sector-wide multiple compression and concerns over meeting long-term FY31 revenue guidance.
π» Marvell maintains key supplier agreements with hyperscalers, including a notable custom silicon deal with Google supporting AI growth.
π Analysts reference management's investor day frameworks outlining long-term revenue and EPS targets for the combined entity.
π Valuation models adjusted projected long-term revenue growth from 63.58% to 65.25% and net profit margins from 31.32% to 30.49%.
π The assumed future P/E multiple for Marvell Technology was lowered from 35.03x to 32.83x in updated models.
π¦ The discount rate applied to Marvell's valuation increased slightly from 11.33% to 11.51% reflecting higher perceived risk.
- Analysts at B. Riley and Morgan Stanley see the Lumentum acquisition expanding Marvell's addressable market to approximately US$550 billion by calendar 2030.
- Strong visibility for AI-related growth is supported by existing agreements, such as the Google custom silicon deal, in both custom compute and optics.
- Management has laid out long-term revenue and EPS frameworks at a recent investor day that analysts reference for future valuation.
- Analysts including TD Cowen and BofA warn the Lumentum acquisition will be initially earnings dilutive to Marvell Technology.
- Risks include cyclicality in laser margins, potential customer overlap with Lumentum, and a potentially lengthy regulatory review process.
- Multiple firms reduced price targets to reflect sector-wide multiple compression and deal-related overhang affecting the stock.
- The higher execution bar created by Marvell's own long-dated FY31 targets is contributing to downward revisions in fair value estimates.